Agenus Inc.

Agenus Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
113.28 M
Public Float
79.21 M
Agenus Inc.
Stock Exchange NASDAQ Stock Market
EPS
$0.8
Market Cap
$361.16 M
Shares Outstanding
134.26 M
Public Float
98.67 M

Profile

Address
3 Forbes Road
Lexington Massachusetts 02421
United States
Employees -
Website http://www.agenusbio.com
Updated 07/08/2019
Agenus, Inc. is a clinical-stage immuno-oncology company, which engages in the development and commercialization of technologies to treat cancers and infectious diseases. Its product pipeline includes AGEN1884, Next-gen CTLA-A, AGEN2034, INCAGN1876, INCAGN1949, Prophage, AutoSynVax, PhosphoSynVax, and AS-21 Stimulon. The company was founded by Garo H.

Financials

View All

Garo H. Armen
Chairman & Chief Executive Officer
Timothy R. Wright
Lead Independent Director